Redox control of NLRP3 inflammasome activation in health and disease

Journal of Leukocyte Biology

Volumn 92, Issue 5, 2012, Pages 951-958

  Rubartelli, Anna ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antioxidants; Caspase 1; IL 1 receptor antagonist; IL 1 ; Leaderless secretion; Oxidative stress; ROS

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

AUTOINFLAMMATORY DISEASE; BONE MARROW CELL; ENZYME ACTIVATION; HEALTH; HUMAN; INNATE IMMUNITY; NONHUMAN; OXIDATION REDUCTION STATE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CARRIER PROTEINS; HUMANS; INFLAMMASOMES; INTERLEUKIN-1; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 84868314921     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0512265     Document Type: Review

References (72)

1. Dinarello, C. A. (2011) A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur. J. Immunol. 41, 1203-1217.
2. Auron, P. E., Webb, A. C, Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., Dinarello, C. A. (1984) Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc. Natl. Acad. Sci. USA 81, 7907-7911.
3. March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V., Gillis, S., Henney, C. S., Kronheim, S. R., Grabstein, K., Conlon, P. J., Hopp, T. P., Cosman, D. (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315, 641-647.
4. Blobel, G., Dobberstein, B. (1975) Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J. Cell Biol. 67, 835-851.
5. Muesch, A., Hartmann, E., Rohde, K., Rubartelli, A., Sitia, R., Rapoport, T. A. (1990) A novel pathway for secretory proteins? Trends Biochem. Sci. 15 86-88.
6. Werman, A., Werman-Venkert, R., White, R., Lee, J. K., Werman, B., Krelin, Y., Voronov, E., Dinarello, C. A., Apte, R. N. (2004) The precursor form of IL-1 α is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. USA 101, 2434-2439.
7. Dinarello, C. A. (2010) IL-1: discoveries, controversies and future directions. Eur. J. Immunol. 40 599-606.
8. Rubartelli, A., Cozzolino, F., Talio, M., Sitia, R. (1990) A novel secretory pathway for interleukin-1 β, a protein lacking a signal sequence. EMBO J. 9 1503-1510.
9. Nickel, W., Rabouille, C. (2009) Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell. Biol. 10 148-155.
10. Bianchi, M. E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81 1-5.
11. Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., Cannizzaro, L. A. (1992) Molecular cloning of the interleukin-1 B converting enzyme. Science 256 10-97.
12. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes. Nature 356 768-774.
13. Miura, M., Zhu H., Rotello, R., Hartwieg, E. A., Yuan, J. (1993) Induction of apoptosis in fibroblasts by IL-1 β-converting enzyme a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75 653-660.
14. Martinon, F., Burns, K., Tschopp, J. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10 417-426.
15. Bauernfeind, F., Ablasser, A., Bartok, E., Kim, S., Schmid-Burgk, J., Cavlar, T., Hornung, V. (2011) Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci. 68, 765-783.
16. Fernandes-Alnemri, T., Yu, J. W., Datta, P., Wu, J., Alnemri, E. S. (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509-513.
17. Hornung, V., Ablasser, A, Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., Fitzgerald, K A. (2009) AIM2 recognizes cy-tosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518.
18. Rathinam, V. A, Vanaja, S. K, Fitzgerald, K. A. (2012) Regulation of inflammasome signaling. Nat. Immunol. 13, 333-342.
19. Pétrilli, V., Papin, S., Dostert, C, Mayor, A, Martinon, F., Tschopp, J. (2007) Activation of the NALP3 inflammasome is triggered by low intra cellular potassium concentration. Cell Death Differ. 14, 1583-1589.
20. Walev, I., Reske, K, Palmer, M., Valeva, A, Bhakdi, S. (1995) Potassium-inhibited processing of IL-1β in human monocytes. EMBO J. 14, 1607-1614.
21. Andrei, C, Dazzi, C, Lotti, L., Torrisi, M. R, Chimini, G., Rubartelli, A (1999) The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell 10, 1463-1475.
22. Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Melchiorri, L., Bari-cordi, O. R, Di Virgilio, F. (1997) Extracellular ATP triggers IL-1 βrelease by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159, 1451-1458.
23. Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K A, Latz, E. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal desta-bilization. Nat. Immunol. 9, 847-856.
24. Cruz, C. M., Rinna, A., Forman, H. J., Ventura, A. L., Persechini, P. M., Ojcius, D. M. (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282, 2871-2879.
25. Dostert, C, Pétrilli, V., Van Bruggen, R, Steele, C, Mossman, B. T., Tschopp, J. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677.
26. Hewinson, J., Moore, S. F., Glover, C, Watts, A. G., MacKenzie, A. B.(2008) A key role for redox signaling in rapid P2X7 receptor-induced IL-1β processing in human monocytes. J. Immunol. 180, 8410-8420.
27. Bauernfeind, F., Bartok, E., Rieger, A, Franchi, L., Nunez, G., Hornung, V (2011) Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 187, 613-617.
28. Meissner, F., Molawi, K, Zychlinsky, A. (2008) Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat. Immunol. 9, 866-872.
29. Van Bruggen, R, Köker, M. Y., Jansen, M., van Houdt, M., Roos, D., Kuijpers, T. W., van den Berg, T. K. (2010) Human NLRP3 inflammasome activation is Nox1-4 independent. Blood 115, 5398-5400.
30. Van de Veerdonk, F. L., Smeekens, S.P.,Joosten, L. A, Kullberg, B. J., Dinarello, C. A, van der Meer, J. W., Netea, M. G. (2010) Reactive oxygen species-independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease. Proc. Natl. Acad. Sci. USA 107, 3030-3033.
31. Meissner, F., Seger, R A, Moshous, D., Fischer, A., Reichenbach, J., Zychlinsky, A. (2010) Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 116, 1570-1573.
32. Zhou, R, Yazdi, A. S., Menu, P., Tschopp, J. (2010) A role for mitochondria in NLRP3 inflammasome activation. Nature 46, 221-225.
33. Vince, J. E., Wong, W. W., Gentle, I., Lawlor, K. E., Allam, R, O'Reilly, L., Mason, K, Gross, O., Ma, S., Guarda, G., Anderton, H., Castillo, R, Hacker, G., Silke, J., Tschopp, J. (2012) Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36, 215-227.
34. Shimada, K, Crother, T. R, Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V K, Wolf, A. J., Vergnes, L., Ojcius, D. M., Rentsend-orj, A, Vargas, M., Guerrero, C., Wang, Y, Fitzgerald, K A, Underhill, D. M., Town, T., Arditi, M. (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401-414.
35. Freigang, S., Ampenberger, F., Spohn, G., Heer, S., Shamshiev, A. T., Kisielow, J., Hersberger, M., Yamamoto, M., Bachmann, M. F., Kopf, M. (2011) Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur. J. Immunol. 41, 2040-2051.
36. Wang, Y, De Keulenaer, G. W., Lee, R T. (2002) Vitamin D(3)-up-regu-lated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J. Biol. Chem. 277, 26496-26500.
37. Chutkow, W. A, Birkenfeld, A. L., Brown, J. D., Lee, H. Y, Frederick, D. W., Yoshioka, J., Patwari, P., Kursawe, R, Cushman, S. W., Plutzky, J., Shulman, G. I., Samuel, V T., Lee, R. T. (2010) Deletion of the a-arres-tin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity. Diabetes 59, 1424-1434.
38. Maedler, K, Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A, Kaiser, N., Halban, P. A, Donath, M. Y (2002) Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110, 851-860.
39. Koenen, T. B., Stienstra, R, van Tits, L. J., de Graaf, J., Stalenhoef, A. F.,Joosten, L. A, Tack, C. J., Netea, M. G. (2011) Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1β transcription in human adipose tissue. Diabetes 60, 517-524.
40. Zhou, R, Tardivel, A, Thorens, B., Choi, I., Tschopp, J. (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136-140.
41. Masters, S. L., Dunne, A, Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A, Becker, C., Franchi, L., Yoshihara, E., Chen, Z., Mullooly, N., Mielke, L. A, Harris, J., Coll, R. C, Mills, K. H., Mok, K. H., Newsholme, P., Nuñez, G., Yodoi, J., Kahn, S. E., Lavelle, E. C, O'Neill, L. A. (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat. Immunol. 11, 897-904.
42. Dröge, W. (2002) Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95.
43. Reid, M. B. (2006) Of balance and unbalance. J. Appl. Physiol. 101, 1011-1012.
44. Carta, S., Castellani, P., Delfino, L., Tassi, S., Vené, R., Rubartelli, A. (2009) DAMPs and inflammatory processes: the role of redox in the different outcomes. J. Leukoc. Biol. 86, 549-555.
45. Tassi, S., Carta, S., Vené, R, Delfino, L., Ciriolo, M. R, Rubartelli, A. (2009) Pathogen-induced interleukin-1β processing and secretion is regulated by a biphasic redox response. J. Immunol. 183, 1456-1462.
46. Piccini, A., Carta, S., Tassi, S., Lasiglié, D., Fossati, G., Rubartelli, A. (2008) ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way. Proc. Natl. Acad. Sci. USA 105, 8067-8072.
47. Sato, H., Tamba, M., Ishii, T., Bannai, S. (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455-11458.
48. Angelini, G., Gardella, S., Ardy, M., Ciriolo, M. R, Filomeni, G., Di Tra-pani, G., Clarke, F., Sitia, R, Rubartelli, A. (2002) Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. USA 99, 1491-1496.
49. Vené, R, Delfino, L., Castellani, P., Balza, E., Bertolotti, M., Sitia, R, Rubartelli, A. (2011) Redox remodeling allows and controls B-cell activation and differentiation. Antioxid. Redox Signal. 13, 1145-1155.
50. Tassi, S., Carta, S., Delfino, L., Caorsi, R, Martini, A, Gattorno, M., Rubartelli, A. (2010) Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1β secretion. Proc. Natl. Acad. Sci. USA 107, 9789-9794.
51. Powis, G., Kirkpatrick, D. L., Angulo, M., Baker, A. (1998) Thioredoxin redox control of cell growth and death and the effects of inhibitors. Chem. Biol. Interact. 111-112, 23-34.
52. Ceccarelli, J., Delfino, L., Zappia, E., Castellani, P., Borghi, M., Ferrini, S., Tosetti, F., Rubartelli, A. (2008) The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants. Int. J. Cancer, 123, 1770-1778.
53. Hwang, C, Sinskey, A J. (1991) The role of oxidation-reduction potential in monitoring growth of cultured mammalian cells. In Production of Biologicals from Animal Cells in Culture (Spier, R E., Griffiths, J. B., Meig-nier, B., eds.), Halley Court, Oxford, 548-567.
54. Walloschke, B., Fuhrmann, H., Schumann, J. (2010) Macrophage cell line RAW264.7 but not P-388D1 is an appropriate in vitro model for studying oxidative burst as well as cytokine production in context of fatty acid enrichment. Cell. Immunol. 262, 58-61.
55. Carta, S., Tassi, S., Pettinati, I., Delfino, L., Dinarello, C. A, Rubartelli, A. (2011) The rate of Interleukin-1β secretion in different myeloid cells varies with the extent of redox response to Toll-like receptor triggering. J. Biol. Chem. 286, 27069-27080.
56. Rubartelli, A, Gattorno, M., Netea, M. G., Dinarello, C. A. (2011) Interplay between redox status and inflammasome activation. Trends Immunol. 32, 559-566.
57. Masters, S. L., Simon, A, Aksentijevich, I., Kastner, D. L. (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 27, 621-668.
58. Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A, Jones, J., Rubin, B. I., Kim, H. J., Brewer, C, Zalewski, C, Wiggs, E., Hill, S., Turner, M. L., Karp, B. I., Aksentijevich, I., Pucino, F., Penzak, S. R, Haverkamp, M. H., Stein, L., Adams, B. S., Moore, T. L., Fuhlbrigge, R. C., Shaham, B., Jarvis, J. N., O'Neil, K, Vehe, R. K., Beitz, L. O., Gardner, G., Hannan, W. P., Warren, R. W., Horn, W., Cole, J. L., Paul, S. M., Hawkins, P. N., Pham, T. H., Snyder, C, Wesley, R. A, Hoffmann, S. C, Holland, S. M., Butman, J. A, Kastner, D. L. (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N Engl. J. Med. 355, 581-592.
59. Gattorno, M., Tassi, S., Carta, S., Delfino, L., Ferlito, F., Pelagatti, M. A, D'Osualdo, A., Buoncompagni, A., Alpigiani, M. G., Alessio, M., Martini, A., Rubartelli, A. (2007) Pattern of interleukin-1β secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum. 56, 3138-3148.
60. Carta, S., Tassi, S., Delfino, L., Omenetti, A., Raffa, S., Torrisi, M. R, Martini, A., Gattorno, M., Rubartelli, A. (2012) Deficient production of IL-1 receptor antagonist and IL-6 coupled to oxidative stress in cryopy-rin-associated periodic syndrome monocytes Ann. Rheum. Dis. [Epub ahead of print].
61. Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R, Tedgard, U., Cowen, E. W., Pham, T. H., Booty, M., Estes, J. D., Sandler, N. G., Plass, N., Stone, D. L., Turner, M. L., Hill, S., Butman, J. A., Schneider, R, Babyn, P, El-Shanti, H. I., Pope, E., Barron, K, Bing, X., Laurence, A., Lee, C. C, Chapelle, D., Clarke, G. I., Ohson, K, Nicholson, M., Gadina, M., Yang, B., Kor-man, B. D., Gregersen, P. K, van Hagen, P. M., Hak, A. E., Huizing, M., Rahman, P., Douek, D. C, Remmers, E. F., Kastner, D. L., Goldbach-Mansky, R (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Eng. J. Med. 360, 2426-2437.
62. Dinarello, C. A. (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720-3732.
63. Tanaka, T., Narazaki, M., Kishimoto, T. (2011) Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases. FEBS Lett. 585, 3699-3709.
64. Menazza, S., Blaauw, B., Tiepolo, T., Toniolo, L., Braghetta, P., Spo-laore, B., Reggiani, C, Di Lisa, F., Bonaldo, P., Canton, M. (2010) Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy. Hum. Mol. Genet. 19, 4207-4215.
65. Mitchell, J., Morris, A., de Belleroche, J. (2009) Thioredoxin reductase 1 haplotypes modify familial amyotrophic lateral sclerosis onset. Free Radic. Biol. Med. 15, 202-211.
66. Lehtinen, M. K, Tegelberg, S., Schipper, H., Su, H., Zukor, H., Manni-nen, O., Kopra, O., Joensuu, T., Hakala, P., Bonni, A., Lehesjoki, A. E. (2009) Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J. Neurosci. 29, 5910-5915.
67. Villani, G. R., Di Domenico, C., Musella, A., Cecere, F., Di Napoli, D., Di Natale, P. (2009) Mucopolysaccharidosis IIIB: oxidative damage and cytotoxiccell involvement in the neuronal pathogenesis. Brain Res. 1279, 99-108.
68. Luciani, A., Villella, V. R., Esposito, S., Brunetti-Pierri, N., Medina, D., Settembre, C., Gavina, M., Pulze, L., Giardino, I., Pettoello-Mantovani, M., D'Apolito, M., Guido, S., Masliah, E., Spencer, B., Quaratino, S., Raia, V., Ballabio, A., Maiuri, L. (2010) Defective CFTR induces ag-gresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat. Cell Biol. 12, 863-875.
69. Borghini, S., Tassi, S., Chiesa, S., Caroli, F., Carta, S., Caorsi, R., Fiore, M., Delfino, L., Lasigliè, D., Ferraris, C., Traggiai, E., Di Duca, M., Sant-amaria, G., D'Osualdo A., Tosca, M., Martini, A., Ceccherini, I., Rubar-telli, A., Gattorno, M. (2011) Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation. Arthritis Rheum. 63, 830-839.
70. Bulua, A. C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K. Y., Sack, M. N., Kastner, D. L., Siegel, R. M. (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cyto-kines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J. Exp. Med. 208, 519-533.
71. Keller, M., Rüegg, A., Werner, S., Beer, H. D. (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818-831.
72. Lamkanfi, M., Sarkar, A., Vande Walle, L., Vitari, A. C., Amer, A. O., Wewers, M. D., Tracey, K. J., Kanneganti, T. D., Dixit, V. M. (2010) In-flammasome-dependent release of the alarmin HMGB1 in endotoxemia. J. Immunol. 185, 4385-4392.